Senores makes bold US push with new federal-focused JV

Company leadership is framing the move as transformational.

Apollo Hospitals hosts specialist dialogue on vertigo diagnosis challenges

Hands-on clinical workshop in Bengaluru brings together neurologists, ENT specialists and physicians

EMA moves to cut animal testing with “virtual control groups” in preclinical research

The approach, which could significantly reduce the number of rats used in certain dose-range finding studies

BioE3 policy accelerates India’s biomanufacturing ambitions with biofoundries, AI hubs & space biotech

Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors

FICCI Advantage Healthcare India 2026 honours Fortis Bannerghatta as top kidney transplant centre

A key milestone in this journey has been the introduction of TREAT Program, a first-of-its-kind clinical initiative introduced in India

Molbio’s digital radiology arm secures CE MDR certification for its medical imaging portfolio

Certification by TÜV SÜD Product Service GmbH reinforces the company's commitment to globally benchmarked standards in safety, quality, and performance

Bristol Myers Squibb expands groundbreaking program to close faps in multiple myeloma care

The program, which has been active for over a decade, will now expand its reach, focusing on equitable access to education, resources, and community-driven solutions for patients and care partners

Apollo Hospitals expands air ambulance services offerings

Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers

Bristol Myers Squibb reports positive phase 4 data on Cobenfy for schizophrenia patients

The open-label trial involved 105 adults with schizophrenia who were on a stable dose of an oral atypical antipsychotic for at least six weeks

Wockhardt’s breakthrough antibiotic Zaynich wins key regulatory nod in India